CN1223361C - Decoction for positive reaction of hepatitis B transformation to negative - Google Patents
Decoction for positive reaction of hepatitis B transformation to negative Download PDFInfo
- Publication number
- CN1223361C CN1223361C CNB021317240A CN02131724A CN1223361C CN 1223361 C CN1223361 C CN 1223361C CN B021317240 A CNB021317240 A CN B021317240A CN 02131724 A CN02131724 A CN 02131724A CN 1223361 C CN1223361 C CN 1223361C
- Authority
- CN
- China
- Prior art keywords
- grams
- root
- radix
- viruses
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a medicine for treating hepatitis B viruses, which uses a medical theory mainly using pilose asiabell root, white atractylodes rhizome, bupleurum root, white peony root, hemlock parsley, angelica, red sage root, rhubarb, lespedeza, honeysuckle flower, taraxacum, isatis root, artemisiae scopariae, green tangerine orange peel, aucklandia root, patrinia, glossy privet fruit, matrimony fruit, tortoise plastron glue, talcum, fresh cogongrass rhizome and licorice root. The medicine can inhibit the replication of viruses in bodies after entering the bodies, removing the gene strand of the hepatitis B viruses, killing the viruses inside and outside the liver and eliminating the viruses out of the bodies. The medicine has the theoretical function of protecting cells, and therefore, the curative effect of treatment purposes can be achieved. The medicine can be used for treating hepatitis B viruses, and has the advantages of low cost, high curative rate, no kickback, no toxic or side effect and no relapse after healing. The effective rate can reach 98%, and the curative rate can reach above 85%.
Description
The present invention relates to a kind of medicine for the treatment of hepatitis B.
At present the drug main of treatment hepatitis B will swell liver-protecting tablet with sharp liver, this medicine to the sick killing action of hepatitis B a little less than, the DeGrain of turning out cloudy of HBAg, treatment time are long, and these medicine medicine high prices are expensive, side effect big, cure the symptoms, not the disease, can not eradicate, cure rate is low, easy recurrence.
The purpose of this invention is to provide a kind of medicine for the treatment of hepatitis B virus, curative effect height of the present invention, do not have return jumpings, have no side effect, cost is low, do not recur after healing, this medicine effective percentage can reach 98%, cure rate can reach more than 85%.
The present invention adopts following principle to realize: the present invention adopts prescription handed down from one's ancestors to go through the actual experiment in more than 100 year; after mainly entering human body by medicament of the present invention; inhibition virus is duplicated in human body and hepatitis B virus gene connects; and inside and outside liver, kill virus and get rid of externally, the principle effect of protection cell realizes.
Owing to adopt such scheme, can make the present invention treat hepatitis B virus, cost is low, cure rate is high, do not have and return jumpings, do not recur after having no side effect, healing, and effective percentage can reach 98%, and cure rate is more than 85%.
Below be the present invention's prescription and processing technology in detail, detailed prescription of the present invention: Radix Codonopsis 10 grams, the Rhizoma Atractylodis Macrocephalae 10 grams, Radix Bupleuri 10 grams, the Radix Paeoniae Alba 9 grams, Rhizoma Chuanxiong 10 grams, Radix Angelicae Sinensis 9 grams, Radix Salviae Miltiorrhizae 10 grams, Radix Et Rhizoma Rhei 10 grams, Fructus Gardeniae 10 grams, Flos Lonicerae 15 grams, Herba Taraxaci 15 grams, Radix Isatidis 12 grams, Herba Artemisiae Scopariae 12 grams, Pericarpium Citri Reticulatae Viride 8 grams, the Radix Aucklandiae 8 grams, Herba Patriniae 10 grams, Fructus Ligustri Lucidi 12 grams, Fructus Lycii 10 grams, Colla Plastri Testudinis 10 grams, Talcum 12 grams, fresh Rhizoma Imperatae 30 grams, Radix Glycyrrhizae 3 grams.
Processing technology of the present invention: the selected decontamination of above medicine is got it filled by formula ratio, and slow fire was fried in shallow oil 10 minutes again after boiling with clear water 1000 gram immersions 30---60 minute, with very hot oven heat, filtered surplus medicine 300 grams.Instructions of taking; Decoction being taken warmly, once a day, each one pair (one pair is whole medicaments of above prescription), one after each meal.
Claims (1)
1. medicine for the treatment of hepatitis B virus is characterized in that it is made by following proportion raw material: Radix Codonopsis 10 grams, the Rhizoma Atractylodis Macrocephalae 10 grams, Radix Bupleuri 10 grams, the Radix Paeoniae Alba 9 grams, Rhizoma Chuanxiong 10 grams, Radix Angelicae Sinensis 9 grams, Radix Salviae Miltiorrhizae 10 grams, Radix Et Rhizoma Rhei 10 grams, Fructus Gardeniae 10 grams, Flos Lonicerae 15 grams, Herba Taraxaci 15 grams, Radix Isatidis 12 grams, Herba Artemisiae Scopariae 12 grams, Pericarpium Citri Reticulatae Viride 8 grams, the Radix Aucklandiae 8 grams, Herba Patriniae 10 grams, Fructus Ligustri Lucidi 12 grams, Fructus Lycii 10 grams, Colla Plastri Testudinis 10 grams, Talcum 12 grams, fresh Rhizoma Imperatae 30 grams, Radix Glycyrrhizae 3 grams.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021317240A CN1223361C (en) | 2002-09-09 | 2002-09-09 | Decoction for positive reaction of hepatitis B transformation to negative |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021317240A CN1223361C (en) | 2002-09-09 | 2002-09-09 | Decoction for positive reaction of hepatitis B transformation to negative |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1413662A CN1413662A (en) | 2003-04-30 |
| CN1223361C true CN1223361C (en) | 2005-10-19 |
Family
ID=4746707
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB021317240A Expired - Fee Related CN1223361C (en) | 2002-09-09 | 2002-09-09 | Decoction for positive reaction of hepatitis B transformation to negative |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1223361C (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1314410C (en) * | 2005-06-26 | 2007-05-09 | 史淑珍 | Chinse medicinal formulation for health-care and heptitis treatment |
| CN105148102A (en) * | 2015-10-27 | 2015-12-16 | 郑耀玲 | Traditional Chinese medicine preparation for treating hepatitis B and preparing method thereof |
| CN107029133A (en) * | 2017-04-20 | 2017-08-11 | 蔡信和 | A kind of natural biology degradation element for killing hepatitis B and preparation method thereof |
-
2002
- 2002-09-09 CN CNB021317240A patent/CN1223361C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1413662A (en) | 2003-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101095747A (en) | Chinese traditional medicine for treating various toothache | |
| CN103127406B (en) | Composite kidney-benefiting medicine | |
| CN105998980A (en) | Anti-virus traditional Chinese medicinal composition and preparation method thereof | |
| CN1315457C (en) | Bath liquid used for frostbite nursing and its preparation method | |
| CN102205059A (en) | Chinese herbal medicine composition for treating liver cancer, stomach cancer, lung cancer and leukemia and preparation method thereof | |
| CN101167932A (en) | Traditional Chinese medicine for treating chronic hepatitis B | |
| CN1186687A (en) | Cancer preventing curing medicine series and its preparation | |
| CN101284113A (en) | Yin toxin Qingyuan pellet | |
| CN1218706C (en) | Hepatitis B treaitng pill | |
| CN1223361C (en) | Decoction for positive reaction of hepatitis B transformation to negative | |
| CN104644857A (en) | Traditional Chinese medicine formula for treating acnes | |
| CN101366937A (en) | Chinese medicine for treating colonitis | |
| CN1385191A (en) | Medicine for treating liver disease | |
| CN100335116C (en) | Medicament for treating leprous psora | |
| CN105641128A (en) | Traditional Chinese medicine composition for treating herpes zoster | |
| CN103316283A (en) | Traditional Chinese medicinal composition for treating chronic cholecystitis, and preparation method thereof | |
| CN101670047A (en) | Hepatitis B treating soup | |
| CN106344886A (en) | Chinese medicinal composition for treating and eliminating hypertension | |
| CN1067900C (en) | Medicine bolus for hepatitis B and its preparation | |
| CN105343777A (en) | Heart soothing pills and method for preparing same | |
| CN105663832A (en) | Traditional Chinese medicine composition for treating radiodermatitis | |
| CN104825720A (en) | Traditional Chinese medicine composition for treating dysmenorrhoea | |
| CN103432358B (en) | Medicament for treating psoriasis | |
| CN1634449A (en) | Medicine for treating heart failure, disturbance of the heart rhythm and heart fibrillation and preparation method thereof | |
| CN103565977A (en) | Traditional Chinese medicine composition for treating skin chloasma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |